How to recover the damage caused by the epidemic?
Release time:
2020-07-15
Due to the impact of the new coronavirus epidemic, most industries and enterprises in China experienced an unprecedented "severe winter" test in the Spring Festival of 2020. Even at the moment, more than a month after the resumption of work, the market is at a standstill, the logistics is not smooth, the employee arrival rate, the rate of resumption of work is still an important factor that plagues the enterprise. The economic "shutdown" for more than two months has greatly damaged the vitality of many enterprises, and even many enterprises are facing the dilemma of being helpless. Since mid-February, the focus of national policy has been adjusted to promote the resumption of work and production. Among the eight initiatives proposed at the meeting on February 23 to promote the prevention and control of the new coronary pneumonia epidemic and the deployment of economic and social development, the precise resumption of work and production ranked first. In the recent meetings of the Group, "taking back the losses caused by the epidemic" has also become the most important topic.
So, how can we recover the damage caused by the epidemic?
Look for opportunities in the "harsh winter. The long-running epidemic has hit most companies with no difference, and whether they are good or bad, "getting through" is a major victory. This also means that many industries are passively shuffled, and the market structure will inevitably change. And these changes will be highlighted after the end of the epidemic. Therefore, as we stand the test of the epidemic, we are also faced with new market choices and opportunities, and the key is whether we can see or grasp them. Since the resumption of work, governments at all levels have introduced a number of preferential policies for enterprises to reduce the burden on the return of the market. Enterprise managers should make full use of this opportunity, carefully analyze the market, accurately grasp the trend, and seize those fleeting development opportunities.
is active at "stagnation. In order to get rid of the influence of market stagnation, it is impossible to rely on one enterprise and one link alone. It needs the synergy of the upstream and downstream of the industrial chain and peer enterprises to effectively "activate", which also brings more thinking space to the work of enterprises. For example, in accordance with the requirements of Pu'er City, concrete enterprises mask stock reached 200 before they can resume work, Yunnan peak in mid-February to the local mixing station to give masks, to help them solve the problem of resumption of work at the same time also activated their own downstream market, a small move to make a game of chess "live" up.
Practice internal skills in "idle" time. Because of the impact of the epidemic, many enterprises production, sales pressure plummeted, rare to have "free". This long period of "idle" is easy to let people loose, bring many negative effects. But at the same time, we also have more time than in the past to check and fill the gaps, discover and solve problems, have more time than in the past to train and learn to improve the professional quality of employees, and have more time than in the past to study and think about the future development of the enterprise. No matter management cadres or ordinary employees, they should not let these "idle" be wasted, but should play a positive role in improving their health level and enhancing their "immunity" for future development ".
Innovation management in the "closed" period. Since the resumption of work for more than a month, many people have a deep understanding of the inconvenience caused by the "closure. "Closed" directly affects our work efficiency, and it is not the focus and breakthrough of our management innovation. Not long ago, pharmaceutical sales companies used the form of "online classes" to conduct business training for marketers, and health technology companies participated in online "cloud exhibitions". These are all good practices that have never been done before, but have achieved certain results. If there are more similar innovations and breakthroughs, and if we encounter other "extraordinary environments" in the future, we will be able to do it with ease.
Of course, the string of epidemic prevention and control still cannot be relaxed while we are hard at resuming work and recapturing losses. With the development of the epidemic, the focus of prevention and control has shifted to "anti-import", provinces outside Hubei have lowered the level of emergency response, the arrival of spring also let many people breathe a sigh of relief. However, from the perspective of the international environment, the epidemic prevention and control situation is still grim, more or less will always have an impact on the country. Therefore, as long as the epidemic is not over, we cannot be paralyzed and lax; even after the new crown epidemic has passed, it is very necessary for enterprises to strengthen health and epidemic prevention management and for employees to develop good health and epidemic prevention habits. (Hong Tao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page